Agrimoniin Alleviates Ferroptosis in Cold‐Stored DCD Liver Grafts Through Activation of the Nrf‐2 Pathway
Cell Proliferation · 2026
DOI: 10.1111/cpr.70164 ↗At a glance
Journal article in Cell Proliferation, 2026. Written by Enqiang Chang and 5 co-authors. Institution: Department of Anesthesiology, Guangxi Medical University Cancer Hospital, Guangxi Clinical Research Center for Anesthesiology, Nanning, China. Major MEDLINE topics: NF-E2-Related Factor 2, Liver Transplantation, Ferroptosis, Liver. 41 references. The full text is freely available (open access, CC BY 4.0). Funded by: Natural Science Foundation of Henan Province.
Abstract (original language)
Liver grafts from donation‐after‐cardiac‐death (DCD) are vulnerable to ischemia–reperfusion injury, which compromises graft function after transplantation. Agrimoniin has been shown to possess antioxidant and anti‐inflammatory properties, making it a potential therapeutic agent for organ preservation. This study investigated whether supplementing agrimoniin to the University of Wisconsin (UW) cold storage solution protected liver grafts from DCD rats or cold preserved human liver cell lines (QSG‐7701 and HepG2). Agrimoniin supplementation significantly reduced oxidative damage, alleviated ferroptosis, and mitigated liver injury by activating the Nrf‐2 pathway, both in vivo and in vitro. These findings suggest that ferroptosis is a mediator in DCD liver injury, and agrimoniin, through its activation of the Nrf‐2 pathway, may be an effective therapeutic agent for enhancing liver graft preservation and improving outcomes in DCD liver transplantation.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Anesthesiology, Guangxi Medical University Cancer Hospital, Guangxi Clinical Research Center for Anesthesiology, Nanning, China.
- Division of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Chelsea and Westminster Hospital, London, UK.
- Department of Anesthesiology, Xichang People's Hospital, Xichang, China.
- Department of Anesthesiology, The Maternal and Child Health Care Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
- Department of Anesthesiology, the First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.
ORCID profiles: Enqiang Chang
Funding
- Natural Science Foundation of Henan Province
Cite
APA
Chang, E., Liao, X., Tao, G., Luo, B., He, S., & Pan, L. (2026). Agrimoniin Alleviates Ferroptosis in Cold‐Stored DCD Liver Grafts Through Activation of the Nrf‐2 Pathway. Cell Proliferation. https://doi.org/10.1111/cpr.70164
Vancouver
Chang E, Liao X, Tao G, Luo B, He S, Pan L. Agrimoniin Alleviates Ferroptosis in Cold‐Stored DCD Liver Grafts Through Activation of the Nrf‐2 Pathway. Cell Proliferation. 2026. doi:10.1111/cpr.70164
BibTeX
@article{Chang2026,
author = {Chang, Enqiang and Liao, Xiaoting and Tao, Guanghua and Luo, Bijun and He, Sheng and Pan, Linghui},
title = {Agrimoniin Alleviates Ferroptosis in Cold‐Stored DCD Liver Grafts Through Activation of the Nrf‐2 Pathway},
journal = {Cell Proliferation},
year = {2026},
doi = {10.1111/cpr.70164}
}
EUVIMED